Poland - Anti-cancer agents
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 02 July 2019
- Opportunity publication date
- 06 June 2019
- Category
- 33652100: Antineoplastic agents
- Value of contract
- to be confirmed
- Your guide to exporting
Description
1) Cisplatin ready concentrate for preparation of solution with minimum 48 h 10 mg (1 mg/ml) - 20 vials; 2) Cisplatin ready concentrate for preparation of solution. Cisplatin ready concentrate for preparation of a solution with a minimum physical and chemical stability of 48 h 100 mg (1 mg/ml) - 600 vials. 1 Doxorubicine hydrochloride - ready solution. for injection and infusion 10mg - 80 vials; 2 Doxorubicine hydrochloride - ready solution for injection and infusion 50mg - 700 vials; 3 Doxorubicine hydrochloride - ready solution for injection and infusion 100mg - 300 vials.;4 Doxorubicine hydrochloride - ready-made solution for injection and infusion 200mg - 100 vial. 1 Ifosfamide 1g - 40 vial. 2 Ifosfamide 2g - 80 vial. Ifosfamide 2g - 80 vial. Message solution 400mg or calculated as 200mg - 300 amp. 1 Vinorelbine ready-made concentrate for solution 10mg - 120 vial;2 Vinorelbine ready-made concentrate for solution 50mg - 20 vial. Methotrexate ready-made solution 50mg - 150 amp. Methotrexate 2.5 mg tablets (op. 50 pcs.) - 15 pcs. 1 Carboplatin - ready concentrate for solution for infusion 50mg - 500 vials; 2 Carboplatin - ready concentrate for solution for infusion 150mg - 260 vials; 3 Carboplatin - ready concentrate for solution for infusion 450mg - 300 vials; 4 Carboplatin - ready concentrate for solution for infusion 600mg - 200 vials. 1 Docetaxel ready-made concentrate 20mg - 400 vials;2 Docetaxel ready-made concentrate 80mg - 400 vials;3 Docetaxel ready concentrate 160mg - 50 vials;1 Dacarbazine 100mg - 80 vials;2 Dacarbazine 200mg - 150 vials;3 Dacarbazine 500mg - 150 vials Vinblastine sulfate 5mg with solvent. - 240 vials Vincristine sulfate 1mg ready-made concentrate - 250 vials Bleomycin hydrochloride 15mg - 200 vials 1 Mitomycin 20mg - 10 vials 2 Mitomycin 10mg - 100 vials Mitoxantrone hydrochloride solution 10mg - 20 vials. 1 Cyclophosphamide 1g (substrate soluble in 0.9 % NaCl) - 600 vials; 2 Cyclophosphamide 200mg (substrate soluble in 0.9 % NaCl) - 600 vials. 1 Cyclophosphamide 50mg trays (op. 50 pcs.) - 50 op. Melphalan 2mg tablets (op. 25 pcs.) - 50 pcs. Chlorambucil 2mg tablets (op. 25 pcs.) - 60 op. 1 Etoposide - ready-made concentrate for preparation. 50 mg solution - 50 vials; 2 Etoposide - ready-made concentrate for preparation. 100 mg solution - 100 vials; 3 Etoposide - ready-made concentrate for preparation. solution 200 mg - 200 vials. 1 Fluorouracil solution 5000 mg, no yellowing after preparation of the solution for infusion and physical and chemical stability at least 48 hours after preparation of the solution for the patient. - 1000 vial;2 Fluorouracil solution 1000mg, no yellowing after preparation of the solution for infusion and physical and chemical stability at least 48h after preparation of the solution for the patient. - 100 vials Bicalutamide 50mg tablets (op. 28 pcs.) - 100 op. Ondansetron hydrochloride 8mg (op. 5 ampoules) - 1500 op. Aprepitant 80mg 2 tabl.+125mg 1 tabl.+125mg 1 tabl. - 100 op. 1 Filgrastim 30 million j. ampoule injection. - 200 pieces;2 Filgrastim 48 million j. ampoule injection. - 250 pcs. Vemurafenib 240mg tabl. (op. 56 pcs.) - 60 op. Cobimetinib 20mg tabl. (op. 63 pcs.) - 15 pcs. 1 Gemcitabine-ready concentrate solution for solution for infusion 2000mg - 300 vials; 2 Gemcitabine-ready concentrate solution for solution for infusion 1000mg - 300 vials; 3 Gemcitabine-ready concentrate solution for solution for infusion 200mg - 300 vials. 1 Calcium folinate solution. 500mg, diluted solution physically and chemically stable 48h - 200 vials.;2 Calcium folinate solution. 1000mg, diluted solution physically and chemically stable 48h - 800 vial. 1 Paclitaxel solution. 300mg, solution stability after dilution above 24h - 50 vial. 2 Paclitaxel solution. 600mg, solution stability after dilution above 24h - 400 vial. Erythropoietin beta 30 thousand ampoule syringe - 60 pcs. Darbepoetin alpha 500mcg - 200 pcs. Trastuzumab 600mg/5ml for subcutaneous administration - 600 vials 1 Topotecan - concentrate solution 4mg - 50 vials 2 Topotecan-concentrate solution 2 mg - 80 vials; 3 Topotecan-concentrate solution 1 mg - 50 vials. Temozolomide in capsules 5, 20, 100, 140, 180, 250 mg - 300000 mg 1 Capecitabine 150 mg tablets (op. 60 pcs.) - 200 op.;2 Capecitabine 500 mg tablets (op. 120 pcs.) - 500 op. Cladribine solution 10mg - 25 vials 1 Epirubicin - ready concentrate for preparation 10mg - 150 vials;2 Epirubicin - ready concentrate for preparation 50mg - 100 vials;3 Epirubicin - ready concentrate for preparation 100mg - 50 vials. Imatinib 400mg tablets with registration in GIST (op. 90 pcs.) - 50 op. 1 Irinotecan ready concentrate for solution preparation 300mg - 600 vial; 2 Irinotecan ready concentrate for solution preparation 100mg - 600 vial; 3 Irinotecan ready concentrate for solution preparation. 40mg - 250 vial. 1 Citarabine solution 100mg - 40 vials; 2 Citarabine solution 500mg - 30 vials; 3 Citarabine solution 1000mg - 50 vials Fulvestran 500mg (2 ampoules of 250mg each) - 200 op. 1 Oxaliplatin - ready-made concentrate for preparation. solution 50 mg - 450 vials; 2 Oxaliplatin - ready-made concentrate for preparation. solution 100 mg - 450 vials; 3 Oxaliplatin - ready-made concentrate for preparation. Doxorubicin in pegylated liposomes ready concentrate for preparation. Pegfilgrastim 6mg semi-automatic injector - 300 pcs. 1 Vinorelbine capsules 20mg - 1000 pcs.; 2 Vinorelbine capsules 30mg - 700 pcs. Bortezomide 3.5mg - 650 vial. Netupitant 300mg + palonosetron 0.5mg - 100 pcs. 1 Erlotinib hydrochloride 150mg (op. 30 tabl.) - 40 op. 2 Erlotinib hydrochloride 100mg (op. 30 tabl.) - 10 op. 1 Cetuximab solution 100mg - 600 vials; 2 Cetuximab solution 500mg - 600 vials. Doxorubicin liposomal 50mg powder and components for cleaning the concentrate (op. 2 compl.) - 100 op. Fludarabine phosphate 50mg concentrate in the form of a solution - 75 amp. 1 Imatinib 400mg capsules (op. 30 pcs.) - 10 op.;2 Imatinib 100mg capsules (op. 60 pcs.) - 5 op. 1 Sunitynib 12.5 mg hard capsules (op. 28 pcs.) - 30 pcs. - 2 Sunitynib 25 pcs. hard capsules (op. 28 pcs.) - 50 pcs. - 3 Sunitynib 50 pcs. hard capsules (op. 28 pcs.) - 50 pcs. 1 Bewacizumab 100mg concentrate for solution preparation - 250 vials; 2 Bewacizumab 400mg concentrate for solution preparation - 300 vials. Sorafenib 200mg tabl. film-coated (op. 112 pcs.) - 80 pcs. 1 Lapatinib 250mg tabl. film-coated (op. 140 pcs.) - 60 op.;2 Lapatinib 250mg tabl. pl. (op. 70 pcs.) - 20 op. 1 Panitumumab 100mg - 120 vials; 2 Panitumab 400mg - 120 vials; 1 Pemetrexed 100mg - 100 vials; 2 Pemetrexed 500mg - 80 vials Thalidomide 100mg (op. 30 pcs.) - 200 op. Levofolinic acid 200mg - 400 vials 1 5-Fluorouracil 500mg compatible with levofolinic acid - 100 vials 2 5-Fluorouracil 1000mg compatible with levofolinic acid - 700 vials 1 Octreotidium acetis 30mg - 15 vials 2 Octreotidium acetis 20mg - 5 vials. Lomustyna cap. 40mg (op. 20 pcs.) - 10 pcs. Brentuksymab vedotin 50mg - 70 pcs. Zoledronic acid amp. 4mg - 50 pcs. 1 Everolimus table 5mg (op. 30 pcs.) - 30 op.;2 Everolimus table 10mg (op. 30 pcs.) - 30 op. Lipegfilgraphy 6mg, ampoule syringe - 250 pcs. Rasburykaza 1.5 mg (op. 3 pcs.) - 50 pcs. 1 Bendamustin hydrochloride 25mg (op. 5 vial) - 40 op.; 2 Bendamustin hydrochloride 100mg (op. 5 vial) - 50 op. 1 Ruksolithinib 5mg (op. 56 pcs.) - 10 op. 2 Ruksolithinib 15mg (op. 56 pcs.) - 15 op. 3 Ruksolithinib 20mg (op. 56 pcs.) - 5 op. 1 Lenalidomide 5mg (op. 21 pcs.) - 15 pcs. - 2 Lenalidomide 10mg (op. 21 pcs.) - 40 pcs. - 3 Lenalidomide 15mg (op. 21 pcs.) - 50 pcs. - 4 Lenalidomide 25mg (op. 21 pcs.) - 100 pcs. 1 Lanreotidium 120mg/0.5ml amp.sharp. - 50 pieces;2 Lanreotidem 90mg/0,5ml amp.- sharp. - 20 pieces;3 Lanreotidem 60mg/0,5ml amp.- sharp. - 5 pcs. Dexketoprofen 50mg/2ml (op. 5amp.) - 200 op. Paclitaxel transfusion apparatus - 2000 pcs. 1 Rituximab 100mg/10ml, vial 400 pcs;2 Rituximab 500mg/50ml, vial 250 pcs;3 Rituximab 1400mg/11,7ml, vial 250 pcs. 1 Abiraterone 500mg (op. 60 pcs.) - 150 op. 2 Abiraterone 250mg (op. 120 pcs.) - 100 op. 1 Pazopanib 400mg (op. 60 pcs.) - 150 op. 2 Pazopanib 200mg (op. 30 pcs.) - 50 op. Azacytidine 100mg - 800 pcs. Procarbazinum 50mg cap. (op. 50pcs) - 20 op. 1 Portable infusion system using an elastomer tank and flow limiter, providing 120h continuous drug flow at a nominal flow rate of 2ml/h, nominal volume 240ml up to max. 300ml. The infusion system must be compatible and stable with cytostatic agents, e.g. 5-Fluorouracil. Separately attached bag for the pump. - 120 compa.;2 Portable infusion system using an elastomer tank and flow limiter, providing a continuous drug flow for 48 hours at a nominal flow rate of 5ml/h, nominal volume of 240ml up to max. 300ml. The infusion system must be compatible and stable with cytostatic agents, e.g. 5-Fluorouracil. Separately attached bag for the pump. - 200 Compr.;3 Portable infusion system using an elastomer tank and flow limiter, providing a continuous drug flow for 48 hours at a nominal flow rate of 2ml/h or 2.5ml/h, a nominal volume of 96ml or 120ml up to max. 130ml. The infusion system must be compatible and stable with cytostatic agents, e.g. 5-Fluorouracil. Separately attached bag for the pump. - 250 compa.;4 Portable infusion system using an elastomer tank and flow limiter, providing a continuous drug flow for 22 hours at a nominal flow rate of 5ml/h, nominal volume of 120ml up to max. 130ml. The infusion system must be compatible and stable with cytostatic agents, e.g. 5-Fluorouracil. Separately attached bag for the pump. - 600 Kompl. 1 Aksitinib 1mg (op. 56pcs) - 30 op. 2 Aksitinib 5mg (op. 56pcs) - 20 op. Gefitinib 250mg (op. 30 pcs.) - 15 pcs. Bekssaroten 75mg capsules (op. 100 pcs.) - 30 pcs. Instruments for multiple collection from a bottle containing a cytotoxic drug by aseptic technique, demonstrating stability and compatibility with them (Chemo-Aide or equivalent) - 2000 pcs. 1 Crizotinib 250mg hard capsules (op. 60pcs) - 25 op. 2 Crizotinib 200mg hard capsules (op. 60pcs) - 40 op. Denosumab 120 mg solution 1,7 ml - 20 pcs. Anagrelide 0.5 mg capsules, drug used in I and II cast (op. 100 pcs.) - 150 op. Temsirolimus 30mg concentrate + rozp. - 100 pcs. 1 Dabrafenib 50mg hard cap (op. 28 pcs.) - 10 op. 2 Dabrafenib 75mg hard cap (op. 120 pcs.) - 32 op. 1 Tramline 0.5 mg coated table-top (op. 30 pcs.) - 5 op.;2 Tramline 2 mg coated table-top (op. 30 pcs.) - 32 op. Olaparibum 50mg capsule. (op. 448 pcs.) - 35 op. Obinutuzumab 1g/40ml concentrate to prepare a solution for vial infusion. - 50 pcs. Pertuzumab 420mg/14ml concentrate to prepare a solution for vial infusion. - 50 pcs. Nab-paclitaxel 100mg powder for suspension for vial infusion. - 300 pcs. 1 Trabectedin 0.25mg - 35 pieces; 2 Trabectedin 1mg - 35 pieces. Enzalutamide 40mg capsule. (op. 112 pcs.) - 85 op. Fludarabine phosphate 10mg tabl. film-coated (op. 20 pcs.) - 50 op. Interferon alpha-2b 18 million j. - 400 pcs. Dexamethasone phosphate 4mg/ml covered by the refund for chemotherapy with paclitaxel (op. 5amp.) - 150 op. 1 Nivolumab 40mg/4ml - 144 pcs. 2 Nivolumab 100mg/10ml - 288 pcs. 1 Cabozantinib 20mg (op. 30 pcs.) - 10 op. 2 Cabozantinib 40mg (op. 30 pcs.) - 20 op. 3 Cabozantinib 60mg (op. 30 pcs.) - 20 op. 1 Grenalvon 0.5 mg (Op. 100 pcs.) - 20 pcs. - 2 Grenalvon 1 mg (Op. 100 pcs.) - 20 pcs. 1 Trastuzumab 150mg - 200 pieces;2 Trastuzumab 420mg - 200 pieces. Ibrutinib 140mg (op. 90 pcs.) - 30 op. Pembrolizumab 100mg - 50 pcs. 1 Ozymertynib 40mg (op. 30 pcs.) - 15 op.;2 Ozymertynib 80mg (op. 30 pcs.) - 15 op. Atezolizumab 1200mg/20ml - 50 pcs. Pixantron 29mg - 110 pcs. Tomato 4 mg or 3 mg or 3 mg or 2 mg or 1 mg (op. 21 pcs.) - 36 op. 1 Trastuzumab emtunsine 100mg - 54 pieces;2 Trastuzumab emtunsine 160mg - 54 pieces. Trastuzumab 150mg - 100 pcs. 1 Nintedanibum 150mg (op. 60 pieces) - 20 op. 2 Nintedanibum 100mg (op. 120 pieces) - 50 op. 1 Afatinib 20mg (op. 28 pcs.) - 18 op. 2 Afatinib 30mg (op. 28 pcs.) - 18 op. 3 Afatinib 40mg (op. 28 pcs.) - 18 op.
- Opportunity closing date
- 02 July 2019
- Value of contract
- to be confirmed
About the buyer
- Address
- Szpital Wojewódzki im. Mikołaja Kopernika ul. Chałubińskiego 7 Koszalin 75-581 Poland
- Contact
- bozena.sterczynska@swk.med.pl
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.